Wellington exits Actelion

The Munich venture capitalist sells its DM53.5m stake in the Swiss biotech firm after two years. Morgan Stanley placed the shares with institutional investors.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this